Il Farmaco

Design and development of 2, 3-benzodiazepine (CFM) noncompetitive AMPA receptor antagonists

R Gitto, M Zappalà, G De Sarro, A Chimirri

Index: Gitto, Rosaria; Zappala, Maria; De Sarro, Giovambattista; Chimirri, Alba Farmaco, 2002 , vol. 57, # 2 p. 129 - 134

Full Text: HTML

Citation Number: 27

Abstract

2, 3-Benzodiazepines represent a class of heterocyclic compounds that interact with AMPA- type glutamate receptors in a noncompetitive manner. These compounds have attracted great interest for their pharmacological effects against acute and chronic neurodegenerative diseases, such as ischemia and epilepsy. We synthesized a large number of 2, 3- benzodiazepine derivatives, which showed anticonvulsant properties in different seizure ...

Related Articles:

Solid-phase Friedel–Crafts acylation on polystyrene resins-synthesis of antiepiletic 1-aryl-3, 5-dihydro-4H-2, 3-benzodiazepin-4-ones

[Bevacqua, Francesca; Basso, Andrea; Gitto, Rosaria; Bradley, Mark; Chimirri, Alba Tetrahedron Letters, 2001 , vol. 42, # 43 p. 7683 - 7685]

New PDE4 inhibitors based on pharmacophoric similarity between papaverine and tofisopam

[Bihel, Frederic J.J.; Justiniano, Helene; Schmitt, Martine; Hellal, Malik; Ibrahim, Mohamed A.; Lugnier, Claire; Bourguignon, Jean-Jacques Bioorganic and Medicinal Chemistry Letters, 2011 , vol. 21, # 21 p. 6567 - 6572]

More Articles...